Cassava will stop developing simufilam for Alzheimer’s this year after a Phase 3 trial failed to improve cognition and daily ...

What is buntanetap for Alzheimer’s disease? Buntanetap, previously known as posiphen or ANVS401, is an oral small molecule being investigated as a possible treatment for Alzheimer’s disease. It is ...